Micro algae-Based "Bio-Robots" offer new hope for precision cancer therapy
Researchers from China and the UK have unveiled a novel biotechnology platform that harnesses the porous structures of certain microalgae species to manufacture microscopic bio-robots for targeted cancer treatment.
According to the University of Edinburgh's press service, these micro-scale robots can precisely transport chemotherapy drugs to tumors under the guidance of external magnetic fields, thereby minimizing the systemic burden of treatment on patients.
Zhu Zhi, a researcher at the University of Edinburgh, explained that the disc-shaped microalgae species Coscinodiscus granii serves as the structural foundation for the newly developed bio-robots. "We are able to track their movement within the human body in real time, enabling us to guide them toward tumors and release therapeutic agents once they reach the target tissue," he said.
The research team designed the technology to improve both the safety and effectiveness of bladder cancer treatment. The microscopic robots are built from algal cells loaded with magnetic nanoparticles composed of magnetite, along with the anti-cancer drug doxorubicin.
To protect the therapeutic payload, the structures are coated with a biodegradable polymer layer that seals the pores within the algae's silica framework.
This coating preserves the drug until the robots reach the tumor site and allows researchers to control their movement and monitor their location using external magnetic fields and ultrasound imaging.
To further automate the process, Zhu Zhi and his colleagues developed a neural network capable of tracking the particles within affected organs and optimizing their trajectories to maximize drug concentration at the tumor site.
The system was evaluated in laboratory experiments involving mice implanted with a model of human bladder cancer. The findings demonstrated that the treatment process required only about 30 minutes, while drug concentration within tumors increased by up to tenfold compared with conventional treatment methods.
Moreover, the enhanced drug delivery resulted in an almost complete reduction in tumor size within one week, highlighting the considerable potential of these bio-robots for treating a broad range of malignant tumors.
Challenges in Bladder Cancer Treatment
One of the major limitations in the treatment of many solid tumors is the poor penetration of therapeutic agents into tumor tissues. This often forces clinicians to administer high drug doses, which can lead to severe toxicity, or to seek alternative delivery strategies.
Bladder cancer represents a prominent example of this challenge. Effective treatment frequently requires administering large amounts of chemotherapy directly into affected organs, complicating treatment protocols and increasing the risk of serious adverse effects.
The newly developed bio-robotic system may offer a promising solution to these longstanding challenges in cancer therapy.
